
Iolyx Therapeutics
Manufacturer of a clinical-stage company intending to transform the standard of care for ocular disease at the intersection of immunology and ophthalmology. The company's platform offers tailored form...
Valuation
$64M
Latest known
Share Price
N/A
Total Raised
$45M
Last Round
N/A